AGA Medical Holdings, Inc. (NSDQ:AGAM) posted a 10 percent increase in sales during the second quarter, helping the company reverse a $2 million loss from the same period last year.
For the three month period ended on June 30 the Minneapolis, Minnesota-based company posted a $3.6 million profit on $53.7 million, compared to a $2 million loss on $49.9 million for the same period last year.
For the six month period the company’s net losses widened to $17.5 million on $105 million in sales, compared to a $12.6 million loss on $94 million in sales, according to a prepared release .
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Leerink Swann analyst Rick Wise in a note to investors called the quarterly results “basically in-line” with expectations.
“We continue to view the AGA story as largely on track,” he wrote.
AGA also lowered its sales guidance for 2010 to $217 million for the year, which it blamed on unfavorable currency exchange rates for the Euro. This compares with prior sales guidance of $221 million to $226 million.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
